HeArt Rate and quality of Life in transthyrEtin cardiac amYloidosis (HARLEY)

2024-519107-10-00 Therapeutic use (Phase IV) Authorised, recruitment pending

Status Authorised, recruitment pending · 1 EU/EEA countries · 3 sites

Overview

Sponsor-declared trial summary

Phase Therapeutic use (Phase IV)
Status Authorised, recruitment pending
Participants planned 104
Countries 1
Sites 3

transthyretin cardiac amyloidosis

Key facts

Sponsor
Universita' Degli Studi Di Genova
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Cardiovascular Diseases [C14]
Decision date (initial)
2025-05-27
Transition trial
No
Low-intervention
No
Rare-disease indication
Yes
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

transthyretin cardiac amyloidosis

VersionLevelCodeTermSystem organ class
25.1 LLT 10087643 Transthyretin cardiac amyloidosis 100000004848

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Universita' Degli Studi Di Genova

Sponsor organisation
Universita' Degli Studi Di Genova
Address
Viale Benedetto XV N 6
City
Genoa
Postcode
16132
Country
Italy

Scientific contact point

Organisation
Universita' Degli Studi Di Genova
Contact name
Marco Canepa

Public contact point

Organisation
Universita' Degli Studi Di Genova
Contact name
Marco Canepa

Locations

1 EU/EEA country · 3 investigational sites

By country

CountryMS statusPlanned subjectsSites
Italy Authorised, recruitment pending 104 3
Rest of world 0

Investigational sites

Italy

3 sites · Authorised, recruitment pending
IRCSS Ospedale Policlinico San Martino
CardioToraco Vascolare (DICATOV), Largo Rosanna Benzi 10, 16132, Genova
Università Sapienza, Azienda Ospedaliera Sant’Andrea
UOC Cardiologia, Via di Grottarossa 1035, 00189, Roma
Azienda Ospedaliera Universitaria Careggi
Terapia Cardiaca Intensiva, Largo Brambilla 3, 50134, Firenze

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-12-06 Italy Acceptable
2025-03-19
2025-05-27